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Mechanism of Biosynthesis of
Methylsulfones from PCBs and Related
Compounds
by Takaya Mio* and Kimiaki Sumino*
Mercapto-, methylthio-, methylsulfinyl- and methysulfonyl metabolites of PCBs, 2,5,2',5'-tetrachloro-
biphenyl, 1,3,5-trichlorobenzene and some other chlorobenzenes were identified in adipose tissues of
mice, rats and guinea pigs by using GC/MS/COM systems. By means ofadministration ofCD3-methionine, it
was confirmed thatthe methyl group in methylthio metabolites was derived from the methionine. Moreover,
after pretreatment with either esterification of urinary metabolites in guinea pigs with 1,3,5-trichloro-
benzene and 1,3-dichlorobenzene or N-acetylation after esterification, it was confirmed that cysteinyl-
glycine, cysteine, N-acetylcysteine, cysteamine, mercaptopyruvate, mercaptolactate, mercaptacetate, thiol
and disulfide conjugates were detected as a serial modified derivatives of glutathione moiety.
These results are summarized as a metabolic proposed pathway of halogenated aromatic compounds.
Three routes in pathway correspond to oxygenation (initial route), glutathione thioether disposition
(intermediate route) and sulfoxydation (final route) in connection with both reactive intermediates of
epoxide and thiol. Methylation of the thiol by S-adenosylmethionine may be important in inhibiting
covalent binding ofreactive intermediates with biocomponents, similar to the glutathione conjugation for
the detoxification of epoxide.
Introduction
Methylsulfonylation, the process leadingtotheforma-
tion of mercapto-(-SH), methylthio-(-SCH3), methyl-
sulfinyl-(-SOCH3)andmethylsulfonyl-(SO2CH3) metabo-
lites of xenobiotics, is one of the many novel biological
pathways of metabolism discovered during the past
several years. The serial methylsulfonyl pathway for
xenobiotic metabolism has been studied in numerous
laboratories for numerous compounds such as the drugs
cafffeine (1), bromazepam (2), bromovalerylurea (3),
acetoaminophen (4), alfoqualone (5), and 3-hydroxy-
xanthine (6); pesticides and fungicides, including propa-
chlor (7), napthalene (8), AF-2 (9) and PCNB (10); and
pollutants such as DDE (11), PCBs (11-13), HCB (14)
and monochlorodibenzo-p-dioxin (15). During the time
that xenobiotic thioether derivatives were discovered,
precursors including glutathione, cysteinylglycine, cys-
teine and N-acetylcysteine (mercapturic acid) conju-
gates (2,4,5,7,14) have been reported. Furthermore, it
is believed that serial methylsulfonyl metabolites might
be discovered by more detailed analysis.
*Department ofPublic Health, Kobe University SchoolofMedicine,
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Mechanism of Biosynthesis of
Serial Methylsulfonyl Metabolites
Miller and Miller et al. first reported that methylthio
derivatives of carcinogens such as aminobiphenyl (16),
acetylaminofluorene (17) and dimethylaminoazobenzene
(18) were isolated as alkaline degradation products from
liver protein in rats treated with these compounds.
They proposed that to obtain methylthio derivatives,
the process would involvethe directattachment ofthese
compounds to the sulfur atom of the methionyl residue
ofliverprotein and the splittingofthe methylthiogroup
from the electrophilic intermediate interacting between
the aromatic amine and the methionyl residue in liver
protein (16-18).
The formation of xenobiotic thioether derivatives,
including glutathione, cysteinylglycine, cysteine and
N-acetylcysteine (mercapturic acid) conjugates, is gen-
erally considered a pathway for the detoxification of
reactive intermediates. Forexample, theepoxide (arene
oxide) ofcarcinogenic polycyclic aromatic hydrocarbons
can be metabolized to a glutathione conjugate and
appears asN-acetylcysteine and cysteine derivatives in
urine. Thus, invivo studies forthioether excretion may
indicatethatformation ofachemicallyreactive interme-MIO AND SUMINO
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FIGURE 1. Mass spectra of chlorinated organic compounds in feces afterinterperitoneal administration of2,5,2',5'-tetrachlorobiphenyl.
diate has occurred (19,20). The epoxide ofnaphthalene
would change any hydroxymetabolite nonenzymatically
or would convert the dihydroxy metabolite through the
dihydrodihydroxy metabolite by epoxide hydrolase, or
the glutathione conjugate by glutathione-S-epoxide
transferase. It was proposed by Stillwell et al. (8) that
methanethiol derived fromthe2-keto-4-methylthiobuty-
late form by deamination of methionine was the
nucleophilic agent responsible for the formation of the
methylthio metabolite from the epoxide ofnaphthalene.
In another mechanism, it has been confirmed that the
bromazepam thiol conjugate was produced through
scission of the P C-S bond of the bromazepam cystein
conjugate by P-lyase, which is found in the liver cytosol
(21) or in the intestinal flora of rats (22)., Subse-
quently, a bromazepam methylthio conjugate was pro-
duced by transmethylation from S-adenosylmethionine
to bromazepam thiol conjugate by the thiol-S-methyl-
transferase. Those facts indicate that detection of the
serial methylsulfonyl metabolites of xenobiotics alone
could not explain their carcinogenicity. However, the
findings of serial methylsulfonyl metabolites may indi-
cate that xenobiotics interact with sulfhydryl groups.
In our laboratory, serial methylsulfonyl metabolites
were detected by using GC/MS/COM from the adipose
tissues of mice treated with commercial PCBs (Kane-
chlor-300, 400, -500) or 2,5,2',5'-tetrachlorobiphenyl
(TCB) (23). The PCBs containing 3 to 5 chlorine atoms
clearlyproduced methylsulfonylmetabolites, butJessen
et al. (11) reported that methylsulfonyl metabolites
were found in trichlorinated to heptachlorinated bi-
phenyls. Jansson et al. (12) also reported that the
methylthio metabolite ofhexachlorobenzene was to be a
dechlorinated type of HCB. This finding may possibly
indicate that decachlorinated biphenyl produces serial
methylsulfonyl metabolite. HCB detected in adipose
tissues (24) is known to be one of the contaminants in
various herbicides polluting the environment.
Ten metabolites (Fig. 1) were detected in the feces of
mice treated with 2,5,2',5'-TCB, a major component of
Kanechlor-400. By groups of sulfur-containing metabo-
lites and nonsulfur-containing hydroxy metabolites, the
excretion rates for one week were 1.7% and 43%,
respectively. The amounts of sulfur-containing metabo-
lites were very small, 1:25 compared with metabolites
not containing sulfur (25). Methylsulfonyl metabolites
accumulated in the liver and adipose tissues of mice.
Another paper reported that methylsulfonyl metabo-
lites containing trichlorinated to hexachlorinated bi-
phenyls also accumulated in lungs of mice (26).
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FIGURE 2. Methylsulfonyl metabolic pathway of2,5,2',5'-tetrachlorobiphenyl. Upper pathway: methionine route; lower pathway: cysteine route.
Inthecaseofsimultaneousadministrationof2,5,2',5'-
TCB and CD3-methionine to mice, the SCH3 group of
methylthio metabolite was initially converted to SCD3
group. Later, the SOCH3 moiety of the methylsulfinyl
group was converted to the SOCD3 group (24). It was
confirmed that the methyl moiety in the serial methyl-
sulfonyl metabolite was derived from methionine. Sim-
ilarresults in caffeine were reported by Kameiet al. (1).
After the conversion of hydrogen of the serial methyl-
sulfonyl metabolite to deuterium with D2SO4, a part
of the molecular ion at m/z 252 shifted one mass
unit to the high-mass side. This showed that the 3-
SOCH3-2,5,2',5'-TCB mass peak contained 3-OH-4-
SCH3-2,5,2',5'TCB and 3-SCH3-4-OH-2,5,2',5'-TCB as
the same molecular ions ofthe isomer, suggesting that
the precursor of these metabolites was 2,5,2',5' TCB
epoxide. The epoxide may have been opened by
nucleophilic attack of the sulfhydryl group in cysteine
(as will be described later) and the intermediate subse-
quently converted to the hydroxy metabolite by dehy-
drogenation.
This metabolic process is similar to the metabolic
activation of polycycic aromatic hydrocarbons in each
epoxide, but the product was different from the ulti-
mate carcinogenic form ofbenzopyrene, which was the
7,8-dihydroxy-9,10-epoxide produced through two
epoxidations in one benzene ring (27). The route of
metabolisn of2,5,2',5'-TCB shown in Figure 2 indicates
that PCB was metabolized preferentially in whichever
benzene ring had fewer chlorine atoms. Therefore, in
order to analyze in detail the mechanism for the PCB
metabolism, an experiment using chlorobenzene was
performed. It was confirmed that a methylsulfonyl
metabolite was found in the urine of mice treated with
mono- to tetrachlorinated benzene, but the methylthio
metabolite from HCB was found in smaller amounts
(28). Dichlorobenzenes showed a high excretion rate of
the serial methylsulfonyl metabolite. 1,3,5-Trichloro-
benzeneproduceddichloromethylsulfonylmetabolites of
dechlorinated type resulting from the replacement of
the chlorine atom by a sulfur atom. In the case of
simultaneous administration of 1,3,5-trichlorobenzene
and CD3-methionine to mice, the SCH3 group of the
methylthio metabolite was initially converted to a SCD3
group. Later, the SOCH3 and S02CH3 groups were
converted to SOCD3 and S02CD3 groups just as in
2,5,2',5'-TCB. Furthermore, each methylsulfonyl me-
tabolite contained a hydroxy group in the position
adjacent to the methylsulfonyl group. 2-OH-3-SCH3-
1,5- and 2-OH-3-SH-1,5-dichlorobenzenes were con-
verted to 2-OD-3-SCH3- and 2-OD-3-SD-1,5-dichloro-
benzenes respectively, on treatment with deuterium
sulfide. Bis(2-OH-3-S-1,5-dichlorobenzene) disulfidewas
also found by using GC/MS/.COM.
On administering 1,3,5-trichlorobenzene with gluta-
thione to mice, a hydroxy metabolite not containing
sulfur was detected in quantities as high as in the
control without GSH (3 days urine collection) but the
methylsulfonyl compound was present at levels 1.5
times higher than the control. The excretion ratio of
nonsulfur-containingmetabolitetosulfur-containingme-
tabolite was 1:7.8. After methylation of freeze-dried
urine with hydro-chloric methanol, water-soluble meta-
bolites other than the serial methylsulfonyl metabolite
found were 2-OH-3-mercaptoacetate, -mercaptolactate,
-mercaptopyruvate and -N-acetylcysteine-1,5-dichloro-
benzene. Furthermore afterN-acetylation ofthe water-
solubleresiduewithaceticanhydride, 2-OH-3-mercapto-
131MIO AND SUMINO
GC
(T I M) P3Ps P
150 250 °C
C I
CI CI
145 M+
132
Li
196
160
b'LI . I .
(M+D,)
197
160
b R
131 ~~1941
166
141 176
(M+D2)'
:196 '4
M+
193 208
129 165 (M +D3)
1571.1 175 L
21
(M+Di)+
193 209
129 165
LlL I::. 175
MC I
121194 ~g 234 266
O
127 ~~ ~~iCI S-CH2-COOCH3
CI
tyOH
14
CI
tOD
13
cc
Ci
OH
CI
OD
I SD
11
:
15
cr:
CI
OH
C S-CH3 16
CI
C 1Ih S-CH3 17 r
209 + ci
lx ~149 165177 193 227- 18,
207 M+ CI
294 ofl KL i 28296234 r ' . S-CH2-9
207 I
19 ' 29 l1(
O l
w .~~2436 2718 C S-CH2-6-H2
[~~L~L.JJ 60CH3
L 4. .
194 m + 3 ,
. ...236 278 OH NH2
194 2 1 246 278 §110 37 [ 2071 f
L1194 jjj 236~ F14211 24 2733 1.207 32240 mo
194 kiI I379 K ~~236
194 ci38
200 250 209 ci
j_ 149 165177 193 | | ;C3
OH OOC -0C-CH3
(17) 4
C I S-CH2-CH-CO-NH-CH2-COOCH3
FIGURE 3. Gas chromatograms and mass spectra of urine after intraperitoneal administration of 1,3,5-trichlorobenzene. Broken lines
(D1, D2) represent mass spectra after conversion ofhydrogen into deuterium; D3 represents CD3.
ethylamine (cysteamine), -cysteine and -cysteinylgly-
cine-1,5-dichlorobenzene were found in addition to the
previous metabolites (29). In 1,3-dichlorobenzene,
metabolites of mercaptoacetate, mercaptolactate, mer-
captopyrvate, cysteamine, cysteine, N-acetylcysteine,
cysteinylglycine and thiol dimer were also detected.
Figure 3 shows the gas chromatogram and mass spectra
ofpeak components on the gas chromatogram of 1,3,5-
trichlorobenzene metabolites in mouse urine. Those
conjugates have been considered to be the customery
metabolic products of halobenzenes. The results are
summarized for one metabolic model for halogenated
aromatic compounds in Figure 4. Three routes, as
shown in Figure 4, correspond to oxygenation (upper
route), glutathione thioether disposition (middle cycle)
and sulfoxydation (under route) in connection with both
reactive intermediates ofepoxide andthiol. Methylation
of the thiol from S-adenosylmethionine may be impor-
tant in inhibitingcovalent binding ofreactive intermedi-
ates with biocomponents, similar to the glutathione
conjugation for the detoxification of epoxide. Subse-
quently, sulfoxydation of the methylthiol metabolite to
the methylsulfonyl derivative will result in a decrease in
the molecular polarity of this metabolite and induce
slow excretion of the methylsulfonyl metabolite.
For example, mice receiving 1-SCH3-3,5-dichloro-
benzene completed excretion of this compound in an
unchanged form after 6 hr, but mice treated with
1-SO2CH3-3,5,-dichlorobenzene took 240 hr for excre-
tion. Comparing 1-SO2CH3-3,5-dichlorobenzene with
phenobarbital administration in mice, the amount of
cytochrome P-450 in liver microsome treated with
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FIGURE 4. Metabolic model of halogenated aromatic hydrocarbons.
methylsulfone was 18 times higher than that treated
with phenobarbital. Therefore, Kimura et al. (30) sug-
gested that the substance inducing mixed-function
oxidase was the methylsulfone metabolite produced
from treated compounds. 4-Chlorothiophenyl glucuron-
ide was found in urine from rats treated with O-ethyl-S-
4-chlorophenyl ethane phosphonodithioate with 4-chlo-
rophenylmethylsulfonyl metaboliteproduced. The amount
ofglucuronic metabolite excreted was 1/8 ofthe methyl-
sulfonyl metabolite (31). Generally, glucuronidation of a
hydroxy (phenolic) metabolite provides protection from
phenolic compounds affecting the mitochondria as the
uncoupler in the energy transfer system. Glucuroni-
dation ofthe thiophenolic compound might also have the
same function.
Excretion Routes of Xenobiotic
Compounds
Excretion pathways ofxenobiotic metabolites consist
of two main routes: in the feces and in the urine. Low
molecular weight compounds will be excreted into the
urine, but higher molecular ones will be excreted into
FIGURE 5. Recycling of glutathione conjugates and its derivatives
in vivo. The schematic at left shows nephrohepatic circulation for
low molecular weight conjugates; the right shows enterohepatic
circulation for high molecular weight conjugates. Lac = lactate;
Ace = acetate; Et(NH2) = ethylamine.
the bile and mixed with digested foods and intestinal
microorganisms in the intestinal tract. PCB, DDE,
PCT, polychlorinated dibenzo-p-dioxin (PCDD) and
related metabolites are considered to belong to the
latter. Bakke et al. (7) pointed out that the process of
cleavage ofthe C-S bond ofmetabolites was thought to
be catalyzed by C-S lyase of intestinal microorganism
and intestinal tissues. In the case ofalfoqualone, serial
methylsulfonyl metabolite in urine decreased signifi-
cantly on antibiotic treatment or bile duct ligation. At
the same time, the N-acetylcysteine ofafloqualone was
detected as a metabolite in bile duct, and residual half
components were assumed to be glutathione and cyste-
ine conjugates of afloqualone (32).
The chemical forms ofmethylmercury in the bile duct
are thought to be the glutathione and cysteine conju-
gates (33). This glutathione conjugate may be con-
verted to cysteine conjugate through cysteinylglycine
conjugate by -y-glutamyltranspeptidase and cysteinyl-
glycinase in the bile duct. An analogous phenomenon
may occur in primary urine due to the high activity of
these enzymes inthebrush borderofthe kidneytubules
(34).
Figure 5 shows the biotransformation and circulation
ofxenobiotics. The circulation process is separated into
two routes and two compounds according to molecular
weight: high molecular weight compounds in the
enterohepatic circulation and low molecular weight
compounds in the nephrohepatic circulation. The gluta-
thione conjugate is finally converted to a cysteine or
thiol conjugate, and then two conjugates are trans-
located into the liver. The thiol conjugate derived from
cl+0
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cysteine moiety derivatives is transmethylated by thiol-
S-methyltransferase and is oxygenated by cytochromes
P-450 and P-448 oxidase or is glucuronidated by UDP-
glucuronyltransferase in the liver. The end form of the
thiol conjugate may be represented as a methylsulfone
or glucuronidated conjugate. If the chemical form
inducing cytochrome P-450 were in the methylsulfonyl
form of xenobiotic compounds, both enterohepatic and
nephrohepatic circulations might be important for the
rapid detoxification by mixed-function oxidase during
period of introduction of xenobiotics.
Origin of Sulfur Atom in Serial
Methylsulfonyl Group
In order to determine whether the source of the
sulfur atom in serial methylsulfonyl metabolite ofPCBs
and related compound is cysteine or methionine, Berg-
man et al. (35) administered 2,4',5-trichlorobiphenyl
and either radiolabeled 35S-cysteine or 35S-methionine
to mice. Theresults showed that the labeled sulfur atom
from both cysteine and methionine was incorporated
into the methylsulfonyl group of the biphenyl metabo-
lites, which was detected by using thin-layer radiochro-
matography from the lung extract of mice. Methionine
could possibly be metabolized into cysteine through
cystathionine, but it could not be formed from cysteine
since it is essential in mammals. It is quite certain that
the sulfuratomdonatedtothesulfur-containingmetabo-
lite comes from the sulfhydryl group of cysteine. In
another study by Tulp et al. (15), monochlorodibenzo-p-
dioxin was metabolized to the methylthio derivative,
but the fate of PCDF was not described.
In our laboratory, it was confirmed that the C-S
splitting of S-methylmercuric cysteine and S-methyl-
mercuric cysteamine conjugate caused the formation of
bis(methylmercuric)sulfide, andthatthemethylmercury
covalently bound to the sulfhydryl residue in albumin
was released with the anion exchange reaction by
hydrodisulfide such as thiocysteamine and thiotaurine.
Methylmercuric thiocysteamine and thiotaurine also
converted nonenzymatically to bis(methylmercuric)
sulfide (36).
Conclusion
The formation ofserialmethylsulfonyl metabolites for
xenobiotics will be summarized as follows. The incorpo-
ration of sulfur atom into the xenobiotics starts from
glutathione conjugation in liver, and thiol derivatives
are successivelyproducedbythe cleavage ofglutathione
moiety. The thiol derivative is converted to the methyl-
thio derivative by the transmethylation from S-adeno-
sylmethionine by the action of thiol-S-methyltransfer-
ase. This methylthio derivative changes to a methyl-
sulfonyl derivative through methylsulfinyl form by
S-oxygenation by the action of mixed function oxidase.
The other route to the methylthio derivative may start
from the methionine through reactive intermediates.
Many xenobiotics might have as a metabolic process
these methylsulfone routes. However, it is necessary to
determine the biological effects in each of the methyl-
sulfonyl metabolites for xenobiotics.
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